Study of outcome measures in muscular dystrophy clinical trials
Not Applicable
- Conditions
- Duchenne muscular dystrophy
- Registration Number
- JPRN-UMIN000018235
- Lead Sponsor
- Muscular Dystrophy Clinical Trial Network
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
a) Patients with obvious heart failure and respiratory failure in the judgement of principal investigator or sub-investigator. b) Patients with persistent artificial ventilation (excepting the use of Noninvasive Positive Pressure Ventilation (NPPV) at night). c) Patients with behavioral problems interfered with motor function test such as intellectual disability, autism, attention-deficit hyperactivity disorder in the judgement of principal investigator or sub-investigator. d) Patients who were considered inappropriate for this study by principal investigator or sub-investigator for other reason. e) Patients who are part of other clinical trials now.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method